Sustained elevated levels of C-reactive protein and ferritin in pulmonary tuberculosis patients remaining culture positive upon treatment initiation

PLoS ONE

Volumn 12, Issue 4, 2017, Pages

  Miranda, Pryscila ^a   Gil Santana, Leonardo ^b,c,d   Oliveira, Marina G ^a   Mesquita, Eliene D D ^e   Silva, Elisangela ^f,g   Rauwerdink, Anneloek ^h   Cobelens, Frank ^h   Oliveira, Martha M ^b,g   Andrade, Bruno B ^b,c,d,g,i,j   Kritski, Afrânio ^a,g  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER)   (Brazil)

^d Curso de Medicina   (Brazil)

^e Ary Parreiras Institute Rio de Janeiro State Secretary of Health   (Brazil)

^f STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^g Rede Brasileira de Pesquisa em Tuberculose Rede TB   (Brazil)

^h AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

ⁱ ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^j Universidade Salvador   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FERRITIN; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ADULT; AGED; ARTICLE; BACTERIAL LOAD; BACTERIUM CULTURE; BRAZILIAN; COHORT ANALYSIS; FEMALE; HUMAN; LONGITUDINAL STUDY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SPUTUM ANALYSIS; SPUTUM CULTURE; METABOLISM; MIDDLE AGED; TUBERCULOSIS, PULMONARY;

ADULT; ANTITUBERCULAR AGENTS; C-REACTIVE PROTEIN; FEMALE; FERRITINS; HUMANS; MALE; MIDDLE AGED; TUBERCULOSIS, PULMONARY;

EID: 85017120885     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0175278     Document Type: Article

References (26)

1. World Health Organization (2015) Global tuberculosis report 2015. http://apps.who.int/iris/bitstream/ 10665/191102/1/9789241565059-eng.pdf?ua=1 (assessed on 11/12/2016)
2. World Health Organization (2015) Fact sheets on tuberculosis; Multidrug-Resistant Tuberculosis (MDR-TB): 2015 Update. http://www.who.int/tb/challenges/mdr/mdr-tb-factsheet.pdf (assessed on 11/ 12/2016)
3. Petersen E, Chen LH (2015) Reflections on travel-associated infections in Europe. Lancet Infect Dis 15: 6-8. https://doi.org/10.1016/S1473-3099(14)71055-2 PMID: 25477023
4. Clifford V, Zufferey C, Street A, Denholm J, Tebruegge M, Curtis N (2015) Cytokines for monitoring anti-tuberculous therapy: A systematic review. Tuberculosis (Edinb) 95: 217-228.
5. Walzl G, Haks MC, Joosten SA, Kleynhans L, Ronacher K, Ottenhoff TH (2014) Clinical immunology and multiplex biomarkers of human tuberculosis. Cold Spring Harb Perspect Med 5.
6. Wallis RS, Maeurer M, Mwaba P, Chakaya J, Rustomjee R, Migliori GB, et al. (2016) Tuberculosis - advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers. Lancet Infect Dis 16: e34-46. https://doi.org/10.1016/S1473-3099(16)00070-0 PMID: 27036358
7. Jacobs R, Tshehla E, Malherbe S, Kriel M, Loxton AG, Stanley K, et al. (2016) Host biomarkers detected in saliva show promise as markers for the diagnosis of pulmonary tuberculosis disease and monitoring of the response to tuberculosis treatment. Cytokine 81: 50-56. https://doi.org/10.1016/j. cyto.2016.02.004 PMID: 26878648
8. Kuznetsov IA, Rasulov MM, Iskakova JT (2013) Iron-containing proteins lactoferrin and ferritin in biological media of patients with pulmonary tuberculosis. Bull Exp Biol Med 154: 618-621. PMID: 23658882
9. Minchella PA, Donkor S, Owolabi O, Sutherland JS, McDermid JM (2015) Complex anemia in tuberculosis: the need to consider causes and timing when designing interventions. Clin Infect Dis 60: 764-772. https://doi.org/10.1093/cid/ciu945 PMID: 25428413
10. Bouharras El Idrissi H, Molina Lopez J, Perez Moreno I, Florea DI, Lobo Tamer G, Herrera-Quintana L, et al. (2015) Imbalances in Protein Metabolism in Critical Care Patient with Systemic Inflammatory Response Syndrome at Admission in Intensive Care Unit. Nutr Hosp 32: 2848-2854. https://doi.org/10. 3305/nh.2015.32.6.9827 PMID: 26667743
11. Koethe JR, Blevins M, Nyirenda C, Kabagambe EK, Shepherd BE, Wester CW, et al. (2011) Nutrition and inflammation serum biomarkers are associated with 12-week mortality among malnourished adults initiating antiretroviral therapy in Zambia. J Int AIDS Soc 14: 19. https://doi.org/10.1186/1758-2652-14-19 PMID: 21477359
12. Tacke F, Nuraldeen R, Koch A, Strathmann K, Hutschenreuter G, Trautwein C, et al. (2016) Iron Parameters Determine the Prognosis of Critically Ill Patients. Crit Care Med 44: 1049-1058. https://doi. org/10.1097/CCM.0000000000001607 PMID: 26934143
13. Reddy PV, Puri RV, Khera A, Tyagi AK (2012) Iron storage proteins are essential for the survival and pathogenesis of Mycobacterium tuberculosis in THP-1 macrophages and the guinea pig model of infection. J Bacteriol 194: 567-575. https://doi.org/10.1128/JB.05553-11 PMID: 22101841
14. Tanaka M, Kanamori H, Matsumoto K, Tachibana T, Numata A, Ohashi K, et al. (2015) Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy. Bone Marrow Transplant 50: 727-733. https:// doi.org/10.1038/bmt.2015.17 PMID: 25730191
15. Friis H, Range N, Braendgaard Kristensen C, Kaestel P, Changalucha J, Malenganisho W, et al. (2009) Acute-phase response and iron status markers among pulmonary tuberculosis patients: a cross-sectional study in Mwanza, Tanzania. Br J Nutr 102: 310-317. https://doi.org/10.1017/ S0007114508162122 PMID: 19175946
16. McDermid JM, Hennig BJ, van der Sande M, Hill AV, Whittle HC, Jaye A, et al. (2013) Host iron redistribution as a risk factor for incident tuberculosis in HIV infection: an 11-year retrospective cohort study. BMC Infect Dis 13: 48. https://doi.org/10.1186/1471-2334-13-48 PMID: 23360117
17. Oliveira MG, Delogo KN, Oliveira HM, Ruffino-Netto A, Kritski AL, OliveiraMM (2014) Anemia in hospitalized patients with pulmonary tuberculosis. J Bras Pneumol 40: 403-410. https://doi.org/10.1590/ S1806-37132014000400008 PMID: 25210963
18. Subbian S, Pandey R, Soteropoulos P, Rodriguez GM (2015) Vaccination with an Attenuated Ferritin Mutant Protects Mice against Virulent Mycobacterium tuberculosis. J Immunol Res 2015: 385402.
19. Isanaka S, Aboud S, Mugusi F, Bosch RJ, Willett WC, Spiegelman D, et al. (2012) Iron status predicts treatment failure and mortality in tuberculosis patients: a prospective cohort study from Dar es Salaam, Tanzania. PLoS One 7: e37350. https://doi.org/10.1371/journal.pone.0037350 PMID: 22606361
20. Minchella PA, Donkor S, McDermid JM, Sutherland JS (2015) Iron homeostasis and progression to pulmonary tuberculosis disease among household contacts. Tuberculosis (Edinb) 95: 288-293.
21. Sivakolundu S, Mannela UD, Jain S, Srikantam A, Peri S, Pandey SD, et al. (2013) Serum iron profile and ELISA-based detection of antibodies against the iron-regulated protein HupB of Mycobacterium tuberculosis in TB patients and household contacts in Hyderabad (Andhra Pradesh), India. Trans R Soc Trop Med Hyg 107: 43-50. https://doi.org/10.1093/trstmh/trs005 PMID: 23222944
22. Mayer-Barber KD, Andrade BB, Oland SD, Amaral EP, Barber DL, Gonzales J, et al. (2014) Hostdirected therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511: 99-103. https://doi.org/10.1038/nature13489 PMID: 24990750
23. Plit ML, Theron AJ, Fickl H, van Rensburg CE, Pendel S, Anderson R (1998) Influence of antimicrobial chemotherapy and smoking status on the plasma concentrations of vitamin C, vitamin E, beta-carotene, acute phase reactants, iron and lipid peroxides in patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 2: 590-596. PMID: 9661828
24. Kubica GP, Dye WE, Cohn ML, Middlebrook G (1963) Sputum digestion and decontamination with Nacetyl-L-cysteine-sodium hydroxide for culture of mycobacteria. Am Rev Respir Dis 87: 775-779. https://doi.org/10.1164/arrd.1963.87.5.775 PMID: 13927224
25. World Health Organization (1998) Laboratory Services in Tuberculosis Control, Part II; WHO, editor. Geneva: World Health Organization.
26. Mayfield DG, McLead G, Hall P (1974) The CAGE questionnaire validation of a new alcoholism screening instrument. Am J Psychiatry 131: 1121-1123. https://doi.org/10.1176/ajp.131.10.1121 PMID: 4416585